133 related articles for article (PubMed ID: 36371938)
21. Development and Initial Assessment of [
Carlson ML; Jackson IM; Azevedo EC; Reyes ST; Alam IS; Kellow R; Castillo JB; Nagy SC; Sharma R; Brewer M; Cleland J; Shen B; James ML
Mol Imaging Biol; 2023 Dec; 25(6):1063-1072. PubMed ID: 37735280
[TBL] [Abstract][Full Text] [Related]
22.
An X; Wang J; Tong L; Zhang X; Fu H; Zhang J; Xie H; Huang Y; Jia H
Bioorg Med Chem; 2023 Apr; 83():117233. PubMed ID: 36933438
[TBL] [Abstract][Full Text] [Related]
23. Novel Thienopyrimidine-Based PET Tracers for P2Y
van der Wildt B; Janssen B; Pekošak A; Stéen EJL; Schuit RC; Kooijman EJM; Beaino W; Vugts DJ; Windhorst AD
ACS Chem Neurosci; 2021 Dec; 12(23):4465-4474. PubMed ID: 34757711
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Initial In Vivo Evaluation of [
Tanzey SS; Shao X; Stauff J; Arteaga J; Sherman P; Scott PJH; Mossine AV
Pharmaceuticals (Basel); 2018 Dec; 11(4):. PubMed ID: 30551596
[TBL] [Abstract][Full Text] [Related]
26. 5-(4-((4-[(18)F]Fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: a selective dual inhibitor for potential PET imaging of Trk/CSF-1R.
Bernard-Gauthier V; Schirrmacher R
Bioorg Med Chem Lett; 2014 Oct; 24(20):4784-90. PubMed ID: 25257201
[TBL] [Abstract][Full Text] [Related]
27. One-step
Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
[TBL] [Abstract][Full Text] [Related]
28. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
29. Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders.
Tarale P; Alam MM
Inflammopharmacology; 2022 Jun; 30(3):821-842. PubMed ID: 35290551
[TBL] [Abstract][Full Text] [Related]
30. Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia.
Walker DG; Tang TM; Lue LF
Front Aging Neurosci; 2017; 9():244. PubMed ID: 28848420
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
32. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
Brand C; Longo VA; Groaning M; Weber WA; Reiner T
Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
[TBL] [Abstract][Full Text] [Related]
33. The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke).
Barca C; Foray C; Hermann S; Herrlinger U; Remory I; Laoui D; Schäfers M; Grauer OM; Zinnhardt B; Jacobs AH
Front Immunol; 2021; 12():787307. PubMed ID: 34950148
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
[TBL] [Abstract][Full Text] [Related]
35. Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET).
Lan Y; Bai P; Chen Z; Neelamegam R; Placzek MS; Wang H; Fiedler SA; Yang J; Yuan G; Qu X; Schmidt HR; Song J; Normandin MD; Ran C; Wang C
Acta Pharm Sin B; 2019 Nov; 9(6):1204-1215. PubMed ID: 31867166
[TBL] [Abstract][Full Text] [Related]
36. 18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase.
Horti AG; Wang Y; Minn I; Lan X; Wang J; Koehler RC; Alkayed NJ; Dannals RF; Pomper MG
J Nucl Med; 2016 Nov; 57(11):1817-1822. PubMed ID: 27417650
[TBL] [Abstract][Full Text] [Related]
37. 2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.
Wang JL; Parhi AK; Oya S; Lieberman B; Kung MP; Kung HF
Nucl Med Biol; 2008 May; 35(4):447-58. PubMed ID: 18482682
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
39. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
Lerdsirisuk P; Harada R; Hayakawa Y; Shimizu Y; Ishikawa Y; Iwata R; Kudo Y; Okamura N; Furumoto S
Nucl Med Biol; 2021 Feb; 93():11-18. PubMed ID: 33221641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
